Edition:
United Kingdom

Lonza Group AG (LONN.S)

LONN.S on Virt-X Level 1

267.60CHF
23 May 2018
Change (% chg)

CHF-4.00 (-1.47%)
Prev Close
CHF271.60
Open
CHF270.40
Day's High
CHF270.70
Day's Low
CHF265.10
Volume
344,001
Avg. Vol
418,088
52-wk High
CHF278.40
52-wk Low
CHF189.80

Select another date:

Fri, May 4 2018

UPDATE 1-Lonza confirms targets as gets off to good start

ZURICH, May 4 Swiss drug ingredients maker Lonza confirmed its guidance on Friday and said it had got off to a good start this year.

Lonza confirms targets as Q1 gets off to good start

ZURICH, May 4 Swiss drug ingredients maker Lonza confirmed its guidance on Friday and said it had got off to a good start this year.

Lonza's virus factory shows gene therapy's Texas-sized promise

ZURICH Swiss drugmaker-for-hire Lonza is betting that trillions of customized viruses made at a giant factory in Texas will be the lucrative raw materials of a medical revolution.

FOCUS-Lonza's virus factory shows gene therapy's Texas-sized promise

ZURICH, April 10 Swiss drugmaker-for-hire Lonza is betting that trillions of customized viruses made at a giant factory in Texas will be the lucrative raw materials of a medical revolution.

BRIEF-Lonza To Establish Cell- And Gene-Therapy Centers Of Excellence

* LONZA TO ESTABLISH CELL- AND GENE-THERAPY CENTERS OF EXCELLENCE TO ACCELERATE GROWTH Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Select another date: